First humanized mouse model of chordoma enables testing of promising immune therapies
In recent years, thanks to a string of high-profile success stories, immune therapy has emerged as one of the most … Continue reading
Latest Updates
First clinical guidelines for chordoma treatment published in The Lancet Oncology
This month, chordoma patients, caregivers, and physicians got a powerful new resource to aid in the fight against chordoma with … Continue reading
New chordoma cell lines available to the research community
The Chordoma Foundation has recently awarded $20,000 in prizes to Dr. Silke Brüderlein at the University of Ulm in Germany … Continue reading
Join us for the first Southern California Chordoma Community Conference
As part of the Chordoma Foundation’s continued commitment to serve the chordoma patient community across the country, we invite … Continue reading
New Medical Advisory Board to provide expert counsel on clinical research and patient services
Until now, the Chordoma Foundation has focused primarily on advancing laboratory research to identify potential therapeutic targets and treatment approaches … Continue reading
New service will help patients and caregivers navigate life with chordoma
Dealing with chordoma can be a difficult, confusing, and overwhelming experience. Throughout their journey with the disease, patients, and caregivers … Continue reading
You can’t let a disease run your life
Jeff Schilling credits his wife, Erin, for the philosophy he lives by. “She always drums it into my head that … Continue reading
Personalized medicine comes to chordoma
Featured Researcher: Mrinal Gounder Genetic profiling of a patient’s own tumor could open new avenues for treatment with targeted drug therapies … Continue reading
Standout Chordoma Foundation supporters recognized with second annual Uncommon Awards
Whether as a patient, family member, volunteer, donor, physician, or researcher, our connection to chordoma gives us the chance to … Continue reading
Clinical trials roundtable clarifies path to get drugs approved for chordoma
A global panel of 37 experts has suggested that establishing new clinical trial endpoints—measurements to determine whether a cancer drug … Continue reading